Xconomy San Diego

Altair Therapeutics Changes CEO

Juha-Pekka Tikka5/14/09

San Diego’s Altair Therapeutics today named former Forward Ventures partner Joel Martin as president and CEO. Martin, who left the San Diego life sciences VC firm in October, was previously a co-founder of Avant BioVentures. Altair’s current CEO Paul Brennan will continue working with the company. Privately held Altair, which was founded in 2007, develops therapeutics for respiratory diseases like asthma and rhinitis. Its first compound, an inhaled new class drug, is in Phase 1 clinical trials.

Next Post

Related Topics

Related Posts

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Xconomy Events

Xconomy and Connect present: The Rock Stars of Innovation

Register or Learn More

Xconomy’s Most Popular

  1. The 10 Social News Apps You Need to Try
  2. 7 Lessons from TechStars’ David Cohen on Building a Startup Culture
  3. Q4 Venture Deals, Dollars Stayed Strong, Making 2011 Best in a Decade
  4. With TV App, Dijit Hopes to Ride Out the Coming Apple Revolution in TV
  5. 10 Apps & Sites That Bring Back the Joy of Reading

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.